Display options
Cite
Naguib Leerberg MN, Alme TN, Hansen TW. Metyrapone, an inhibitor of cytochrome oxidases, does not affect viability in a neuroblastoma cell model of bilirubin toxicity. Mol Genet Metab Rep. 2014;1:197-202doi: 10.1016/j.ymgmr.2014.04.002.
Naguib Leerberg, M. N., Alme, T. N., & Hansen, T. W. (2014). Metyrapone, an inhibitor of cytochrome oxidases, does not affect viability in a neuroblastoma cell model of bilirubin toxicity. Molecular genetics and metabolism reports, 1197-202. https://doi.org/10.1016/j.ymgmr.2014.04.002
Naguib Leerberg, Maria N, et al. "Metyrapone, an inhibitor of cytochrome oxidases, does not affect viability in a neuroblastoma cell model of bilirubin toxicity." Molecular genetics and metabolism reports vol. 1 (2014): 197-202. doi: https://doi.org/10.1016/j.ymgmr.2014.04.002
Naguib Leerberg MN, Alme TN, Hansen TW. Metyrapone, an inhibitor of cytochrome oxidases, does not affect viability in a neuroblastoma cell model of bilirubin toxicity. Mol Genet Metab Rep. 2014 Apr 25;1:197-202. doi: 10.1016/j.ymgmr.2014.04.002. eCollection 2014. PMID: 27896088; PMCID: PMC5121316.
Copy Download .nbib Format: NLM
Share it on

Mol Genet Metab Rep. 2014 Apr 25;1:197-202. doi: 10.1016/j.ymgmr.2014.04.002. eCollection 2014.

Metyrapone, an inhibitor of cytochrome oxidases, does not affect viability in a neuroblastoma cell model of bilirubin toxicity.

Molecular genetics and metabolism reports

Maria N Naguib Leerberg, Tomas N Alme, Thor W R Hansen

Affiliations

  1. Department of Pediatric Research, Oslo University Hospital, University of Oslo, Norway.
  2. Department of Neonatology, Women & Children's Division, Oslo University Hospital, Rikshospitalet, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Norway.

PMID: 27896088 PMCID: PMC5121316 DOI: 10.1016/j.ymgmr.2014.04.002

Abstract

BACKGROUND: Unconjugated hyperbilirubinemia may cause brain damage in infants, and globally remains a source of neonatal morbidity and mortality. A significant inter-individual variability in vulnerability to bilirubin toxicity remains largely unexplained. An enzyme located in mitochondria oxidizes bilirubin. We hypothesized that inhibiting bilirubin oxidation in human neuronal cell cultures exposed to bilirubin would increase cell death.

METHODS: The ability of mitochondrial membranes from CHP-212 human neuroblastoma cells to oxidize bilirubin was verified by spectrophotometry. Intact cells in culture were exposed to bilirubin (75 μM) with or without metyrapone (250 μM) for 24 h, stained with Annexin-V and Propidium iodide and analyzed for apoptosis and necrosis by flow cytometry.

RESULTS: Bilirubin caused a significant reduction of viability, from 84 ± 2.0% (mean ± SEM) vs 67 ± 2.7% (p < 0.05), but adding metyrapone to the bilirubin-exposed cells did not further impact cell viability. Metyrapone alone did not influence cell viability.

CONCLUSION: Herein we have shown that metyrapone does not increase cell death in neuroblastoma cells in culture exposed to bilirubin. Our results question the relationship between the oxidative mechanism evaluated by spectrophotometry and cell viability. Our findings add to the discussion on whether bilirubin oxidation represents a potentially important protective mechanism in neurons challenged by hyperbilirubinemia.

Keywords: Bilirubin; Cell culture; Cytochrome P450 oxidase; Kernicterus; Metyrapone; Neurotoxicity

References

  1. Semin Perinatol. 2011 Jun;35(3):114-20 - PubMed
  2. Cytometry. 1998 Jan 1;31(1):1-9 - PubMed
  3. Pediatr Res. 2012 Jun;71(6):653-60 - PubMed
  4. Clin Chem. 1974 Jul;20(7):783 - PubMed
  5. Semin Perinatol. 2011 Jun;35(3):185-91 - PubMed
  6. Biochem Pharmacol. 2005 Nov 15;70(10 ):1527-35 - PubMed
  7. Biol Neonate. 2000 Jul;78(1):68-9 - PubMed
  8. J Clin Invest. 1963 Nov;42:1720-34 - PubMed
  9. Neuromolecular Med. 2006;8(4):513-29 - PubMed
  10. Eur J Biochem. 1969 Oct;10(3):468-73 - PubMed
  11. Semin Perinatol. 2011 Jun;35(3):101-13 - PubMed
  12. Oncogene. 2006 Sep 14;25(41):5683-92 - PubMed
  13. Biol Neonate. 1998;73(2):106-11 - PubMed
  14. Biol Neonate. 1998;73(5):340-5 - PubMed
  15. Biol Neonate. 1996;70(5):289-95 - PubMed
  16. Clin Perinatol. 2006 Dec;33(4):839-52; abstract ix - PubMed
  17. Biochem Mol Med. 1997 Oct;62(1):128-31 - PubMed
  18. Biochem Mol Med. 1997 Apr;60(2):155-60 - PubMed
  19. Curr Pharm Des. 2009;15(25):2884-92 - PubMed
  20. Environ Health Perspect. 2010 Feb;118(2):265-72 - PubMed
  21. Mol Genet Metab. 1999 Nov;68(3):404-9 - PubMed
  22. Biochim Biophys Acta. 2011 Jan;1814(1):94-101 - PubMed
  23. Mol Genet Metab. 2000 Sep-Oct;71(1-2):411-7 - PubMed

Publication Types